Acid-reducing medicine for bleeding in cirrhosis
Part of Digestive system clinical trials.
This trial tests whether a common acid-reducing medicine (a proton pump inhibitor) helps people with cirrhosis who are having bleeding from enlarged veins in the esophagus. The goal is to see if it improves outcomes after emergency treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (liver scarring).
- You had bleeding from enlarged veins in your esophagus, confirmed by a scope within the last 24 hours.
- You are willing to follow the study plan and sign a consent form.
- You have not used a proton pump inhibitor (like omeprazole) for more than 2 weeks before joining.
- You have not had endoscopic or interventional treatment for bleeding in the last 4 weeks.
- You do not have severe kidney disease, advanced liver cancer, or other serious conditions that would make participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether proton pump inhibitors (PPIs) can help people with cirrhosis who are hospitalized for variceal bleeding. It looks at whether PPIs reduce complications during the hospital stay.
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This study compares two ways to prevent future bleeding from enlarged veins in the esophagus or stomach in people with liver cirrhosis. One method uses a small tube (called TIPS) to reduce pressure in the liver, and the other combines a banding procedure with medication. The goal is to see which approach works better.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
Hear when a new Upper Gastrointestinal Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.